[HTML][HTML] Focus: plant-based Medicine and Pharmacology: the Potential for kratom as an Antidepressant and Antipsychotic

LE Johnson, L Balyan, A Magdalany… - The Yale journal of …, 2020 - ncbi.nlm.nih.gov
Mitragyna speciosa, otherwise known as kratom, is a plant in the coffee family (Rubiaceae)
native to Southeast Asia and Thailand whose leaves have been shown to cause opioid-like …

Clinical Implications of Kratom (Mitragyna speciosa) Use: a Literature Review

E Prevete, KPC Kuypers, EL Theunissen… - Current Addiction …, 2023 - Springer
Abstract Purpose of Review This work aims to provide an up-to-date review of the preclinical
and clinical scientific literature on the therapeutic value of kratom to better understand the …

Activity of Mitragyna speciosa (“Kratom”) Alkaloids at Serotonin Receptors

F León, S Obeng, M Mottinelli, Y Chen… - Journal of medicinal …, 2021 - ACS Publications
Kratom alkaloids have mostly been evaluated for their opioid activity but less at other targets
that could contribute to their physiological effects. Here, we investigated the in vitro and in …

Therapeutic benefit with caveats?: Analyzing social media data to understand the complexities of kratom use

KE Smith, JM Rogers, D Schriefer… - Drug and Alcohol …, 2021 - Elsevier
Background Mitragyna speciosa, referred to as “kratom”, is increasingly used in the United
States for self-treating pain, psychiatric, and substance use disorder symptoms. It is used by …

Kratom use as more than a “self-treatment”

KE Smith, KE Dunn, JM Rogers… - The American Journal …, 2022 - Taylor & Francis
Background: Mitragyna speciosa (kratom) is increasingly used in the United States for its
pharmacological effects. Kratom's relative novelty makes for a dynamic situation, such that …

Past-year kratom use in the US: estimates from a nationally representative sample

JJ Palamar - American journal of preventive medicine, 2021 - Elsevier
Introduction Kratom is a plant with partial opioid agonist effects, and its use has become
popular to ameliorate symptoms of opioid withdrawal. However, use has been linked to …

Exploring the self-reported motivations of kratom (Mitragyna speciosa Korth.) use: a cross-sectional investigation

O Grundmann, CA Veltri, D Morcos… - The American Journal …, 2022 - Taylor & Francis
ABSTRACT Background: Kratom (Mitragyna speciosa Korth.) use outside of Southeast Asia
has increased over the past decade. Objectives: This investigation clarifies kratom's role in …

Lyophilized kratom tea as a therapeutic option for opioid dependence

LL Wilson, HM Harris, SO Eans, AC Brice-Tutt… - Drug and Alcohol …, 2020 - Elsevier
Background Made as a tea, the Thai traditional drug “kratom” reportedly possesses
pharmacological actions that include both a coca-like stimulant effect and opium-like …

Accelerated Solvent Extractions (ASE) of Mitragyna speciosa Korth. (Kratom) Leaves: Evaluation of Its Cytotoxicity and Antinociceptive Activity

YS Goh, T Karunakaran, V Murugaiyah, R Santhanam… - Molecules, 2021 - mdpi.com
Mitragyna speciosa Korth (kratom) is known for its psychoactive and analgesic properties.
Mitragynine is the primary constituent present in kratom leaves. This study highlights the …

Searching for a signal: Self-reported kratom dose-effect relationships among a sample of US adults with regular kratom use histories

KE Smith, JM Rogers, KE Dunn… - Frontiers in …, 2022 - frontiersin.org
There is limited understanding regarding kratom use among US adults. Although
motivations for use are increasingly understood, typical kratom doses, threshold of (low and …